Literature DB >> 16501257

Role of tyrosine kinase Csk in G protein-coupled receptor- and receptor tyrosine kinase-induced fibroblast cell migration.

Deirdre McGarrigle1, Dandan Shan, Shengyu Yang, Xin-Yun Huang.   

Abstract

Tyrosine kinase Csk is essential for mouse embryonic development. Csk knock-out mice died at early stages of embryogenesis (around embryonic day 10). The molecular mechanism for this defect is not completely understood. Here we report that Csk deficiency in mouse embryonic fibroblast cells blocked cell migration induced by lysophosphatidic acid through G protein-coupled receptors, by platelet-derived growth factor and epidermal growth factor through receptor tyrosine kinases, and by serum. Re-expression of Csk in these Csk-deficient cells rescued the migratory phenotype. Furthermore, deletion of Csk did not interfere with Rac activation and lamellipodia formation, but impaired the focal adhesions. Our data demonstrate a critical role for Csk in cell migration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501257     DOI: 10.1074/jbc.M513002200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  cAMP inhibits cell migration by interfering with Rac-induced lamellipodium formation.

Authors:  Lin Chen; J Jillian Zhang; Xin-Yun Huang
Journal:  J Biol Chem       Date:  2008-03-19       Impact factor: 5.157

2.  Caspase-3 regulates catalytic activity and scaffolding functions of the protein tyrosine phosphatase PEST, a novel modulator of the apoptotic response.

Authors:  Maxime Hallé; Ying-Chih Liu; Serge Hardy; Jean-François Théberge; Christophe Blanchetot; Annie Bourdeau; Tzu-Ching Meng; Michel L Tremblay
Journal:  Mol Cell Biol       Date:  2006-11-27       Impact factor: 4.272

3.  GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.

Authors:  Jianwei Sun; Huifang He; Smitha Pillai; Yin Xiong; Sridevi Challa; Liyan Xu; Srikumar Chellappan; Shengyu Yang
Journal:  J Biol Chem       Date:  2013-11-14       Impact factor: 5.157

4.  Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells.

Authors:  Pallabita Chowdhury; Prashanth K B Nagesh; Elham Hatami; Santosh Wagh; Nirnoy Dan; Manish K Tripathi; Sheema Khan; Bilal B Hafeez; Bernd Meibohm; Subhash C Chauhan; Meena Jaggi; Murali M Yallapu
Journal:  J Colloid Interface Sci       Date:  2018-09-22       Impact factor: 8.128

5.  Transcriptome profiles discriminate between Gram-positive and Gram-negative sepsis in preterm neonates.

Authors:  María Cernada; Alejandro Pinilla-González; Julia Kuligowski; José Manuel Morales; Sheila Lorente-Pozo; José David Piñeiro-Ramos; Anna Parra-Llorca; Inmaculada Lara-Cantón; Máximo Vento; Eva Serna
Journal:  Pediatr Res       Date:  2021-03-25       Impact factor: 3.756

6.  STIM1 overexpression promotes colorectal cancer progression, cell motility and COX-2 expression.

Authors:  J-Y Wang; J Sun; M-Y Huang; Y-S Wang; M-F Hou; Y Sun; H He; N Krishna; S-J Chiu; S Lin; S Yang; W-C Chang
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

7.  FAK/src-family dependent activation of the Ste20-like kinase SLK is required for microtubule-dependent focal adhesion turnover and cell migration.

Authors:  Simona Wagner; Chris J Storbeck; Kristin Roovers; Ziad Y Chaar; Piotr Kolodziej; Marlene McKay; Luc A Sabourin
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

8.  Pancreatic tumor cell secreted CCN1/Cyr61 promotes endothelial cell migration and aberrant neovascularization.

Authors:  Gargi Maity; Smita Mehta; Inamul Haque; Kakali Dhar; Sandipto Sarkar; Sushanta K Banerjee; Snigdha Banerjee
Journal:  Sci Rep       Date:  2014-05-16       Impact factor: 4.379

9.  C-terminal Src kinase-mediated EPIYA phosphorylation of Pragmin creates a feed-forward C-terminal Src kinase activation loop that promotes cell motility.

Authors:  Yoshie Senda; Naoko Murata-Kamiya; Masanori Hatakeyama
Journal:  Cancer Sci       Date:  2016-06-13       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.